spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ReValving 

 HSMN NewsFeed - 15 Jan 2014
Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 1 Apr 2010
Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 9 Apr 2009
Medtronic Completes Acquisition of CoreValve Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 23 Feb 2009
Medtronic to Acquire CoreValve, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2009
Edwards Lifesciences' Transcatheter Valve Patent Found Valid in UK Court
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 16 Oct 2008
German Court Finds Edwards Lifesciences' Transcatheter Valve Patent Not Infringed by CoreValve
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 16 Oct 2008
CoreValve Wins Patent Infringement Action in Germany
Devices Cardiology Litigation
 HSMN NewsFeed - 13 Oct 2008
CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving(R) System for Percutaneous Aortic Valve Replacement (PAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Sep 2008
CoreValve Announces Successful Completion of Initial Series of Proctored Cases in Australia and New Zealand Using Its ReValving(R) System for Percutaneous Aortic Valve Replacement
Devices Cardiology
 HSMN NewsFeed - 28 Aug 2008
CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving(R) System for Percutaneous Aortic Valve Replacement
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2008
CoreValve announces that more than 1,000 high-risk patients have been treated with its ReValving(R) System for percutaneous aortic valve replacement (PAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 2 May 2008
CoreValve Names Vito A. Canuso III as Vice President, Intellectual Property
Devices Cardiology Personnel
 HSMN NewsFeed - 30 Apr 2008
CoreValve Names Daniel T. Lemaitre as Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 15 Feb 2008
CoreValve Refutes Alleged Patent Infringement Action by Edwards Lifesciences
Devices Cardiology Litigation
 HSMN NewsFeed - 12 Feb 2008
Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
Devices Cardiology Litigation
 HSMN NewsFeed - 7 Jan 2008
CoreValve announces that more than 500 high-risk patients have been treated with its ReValving(R) System for percutaneous aortic valve replacement (PAVR)
Devices Cardiology
 HSMN NewsFeed - 24 Oct 2007
CoreValve's 18-French ReValving(TM) System for percutaneous aortic valve replacement (PAVR) demonstrated 'live' at TCT 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2007
Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve
Devices Cardiology Litigation
 HSMN NewsFeed - 28 Mar 2007
CoreValve Completes $33 Million Private Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 18 Jan 2007
CoreValve Announces the Appointment of Dolf Meewis as Vice President of International Sales
Devices Cardiology Personnel
 HSMN NewsFeed - 6 Dec 2006
CoreValve announces that its 18-French ReValving(TM) Phase III international clinical trial is now one-third enrolled since commencing less than three months ago
Devices Cardiology
 HSMN NewsFeed - 30 Nov 2006
CoreValve Establishes Revalving(Tm) as Repeatable, Pure Cath-Lab Procedure for PAVR on a Beating Heart: No Cardiac Assistance (Neither Mechanical Assistance, Drug-Induced Hypotension or Rapid Pacing) and No Surgical Vessel Cut-Down
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Nov 2006
First Percutaneous Aortic Valve Replacement (PAVR) Procedure without Any Cardiac Support (i.e., Mechanical Assistance or Accelerated Pacing) Performed with CoreValve's Non-Surgical ReValving(TM) System
Devices Cardiology
 HSMN NewsFeed - 24 Oct 2006
CoreValve's 18-French Revalving(TM) System Demonstrated 'Live' at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Oct 2006
CoreValve announces successful completion of world's first 'pure' percutaneous aortic valve replacement (PAVR) procedure utilizing its patented ReValving(TM) system
Devices Cardiology
 HSMN NewsFeed - 12 Jul 2006
CoreValve reports new milestone: ReValving(TM) procedures are performed (a) without extracorporeal bypass, (b) without respiratory assistance, and (c) without intubation and full anesthesia
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Jun 2006
CoreValve Completes Enrollment of Its 'second-generation 21-French' ReValving(TM) System International Clinical Trial for Non-Surgical Replacement of the Diseased Aortic Heart Valve of Patients Not Eligible for Open-Heart Surgery
Devices Cardiology
 HSMN NewsFeed - 11 May 2006
CoreValve Announces 18-French-sized Percutaneous Aortic Valve Replacement (PAVR) Breakthrough Utilizing Its Patented ReValving(TM) System to Non-Surgically Deliver a New Porcine Pericardium Heart Valve over a Severely Diseased Aortic Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Mar 2006
CoreValve names J. C. MacRae as Vice President of Finance and Chief Financial Officer
Devices Cardiology Personnel
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
ReValving
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.